Skip to main content

October 2018

 

 

academics

 

Clinical research courses

Job for M.Pharm, B.Pharm, Pharm.D as Researcher at Cognizant

Cognizant is one of the world's leading professional services companies, transforming clients' business, operating and technology models for the digital era. Our unique industry-based, consultative approach helps clients envision, build and run more innovative and efficient businesses. Headquartered in the U.S., Cognizant is ranked 195 on the Fortune 500 and is consistently listed among the most admired companies in the world.

Post : Researcher

Walk in interview for M.Pharm, M.Sc, B.Pharm in Production, QA, QC, ADL, F&D at Aculife Healthcare

Aculife Healthcare Private Limited, a part of renowned Nirma Group, is one ot the world's largest manufacturer of parenteral, and pharmaceutical formulations under one roof Aculife has been associated with the healthcare segment since over last 30 years now. which is the prime reason why the name spells unparalleled growth and absolute relibility. it has global operations spread across 70 countries including WOS in Mexico and JV in Brazil. Presently, the Company has 8 manufacturing plants backed up by state of the art Aculife Research Centre & 3000 plus Employee base in India & abroad.

OBSESSIVE COMPULSIVE DISORDER AND ITS CARE AN REVIEW

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
1Anjani Srivarsha G , 3Nagavamsidhar M , 4Sai Teja D, 2Qadrie ZL.
1,3,4Research Scholar, Department of Pharmacy Practice, Pratishta Institute of Pharmaceutical Sciences, Suryapet, Hyderabad, Telangana
2 Professor and Head, Department of Pharmacy Practice, Pratishta Institute of Pharmaceutical Sciences, Suryapet, Hyderabad, Telangana

ABSTRACT:
Actually 14 to 16th century in Europe some people have experienced that sexual or other thoughts were by devil then the journey start. 1910, Sigmund Freud said that obsessions and compulsive behaviours are symptoms of OCD. Obsessive compulsory disorder (OCD) is an anxiety disorder. Obsessive compulsive disorder causes the brain stuck on a particular thought or urge. Actually  these  patients  are  having  a obsessive thoughts  means  they  always  occurring  of  images, several  thoughts or pictures over and over in the  mind. These thoughts or rituals can triggered more anxiety. These OCD patients can find out by the facts like washing, cleaning, checking and repeating. The  American  psychiatric  association said  that the females  are  more  affected  then  the  men. The  OCD is  a common , chronic  (long  lasting  disorder)  the  people  with  OCD can  feel  the  temporary  relief  from  the  anxiety if  the  person  can  untreated  then  they  cause  the  more  stress  and  the  effects  seen  on the  work, school  and  lead  to  serious  effects  on personal  relationships. Actually  obsessive compulsive disorder is a brain  injury , it involves  basal  ganglion (Eg: encephalitis  or  trauma) usually  there  is  no  neurologic  precipitant. The  evidence  suggesting  a selective  and  potent  serotonin(5-HT) reuptake  blocker drugs  are  successful  treatment in biological  basis of OCD. The drugs with the other mechanism of action have not been effective more. The neurotransmitter plays an important role in pathophysiology of obsessive compulsive disorder.

7 WAYS TO MAINTAIN HEALTH & FITNESS AT MIDDLE-AGE

Getting older involves lots of emotional and physical which can bring a positive or a negative impact on your health. If you want to age gracefully, you need to have a check on your health at the right time. This can only be done by properly understanding and analyzing the changes in your skin, bones, brain and even behaviour and do the needful to maintain your health. You need not only to exercise but to eat, relax and sleep correctly.

The U.S. Food and Drug Administration approved ID CORE XT, a molecular-based assay used in blood transfusion medicine to help determine blood compatibility. The assay can be used to determine blood donor and patient non-ABO red blood cell (RBC) types. ID CORE XT is the second molecular assay approved for use in transfusion medicine, and the first to report genotypes as final results.

At the function, Shri J P Naddareleased the Position Paper and launched the Information Sharing Platform Gateway for South-East Asia Regulatory Network (SEARN) developed by Centre for Development of Advanced Computing, which will promote regulatory and health collaboration among the countries of the South-East Asia Region.

The Union Health Minister stated that access to medical products and creating an enabling legal and trade environment for public health are critical to achieving the Sustainable Development Goals 2030 Agenda.

“India is deeply committed nationally and globally to achieving all public health goals. Together we are working towards providing highest possible standards of health care for our citizens. Universal health coverage is key to the Sustainable Development Goals 2030 agenda and to which India is firmly committed.” This was stated by Shri J P Nadda, Union Minister of Health and Family Welfare during his address at the inauguration of ‘2nd World Conference on Access to Medical Products: Achieving the SDGs 2030’, here today.

Shri Ashwini Kumar Chaubey, Minister of State (HFW), Smt. Anupriya Patel, Minister of State (HFW), SmtPreeti Sudan, Secretary (Health), Dr.BalramBhargava, Secretary, Dept. of Health & Research (DHR) and DG, ICMR,Dr Mariângela Batista GalvãoSimão, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, WHO Geneva, Dr.PoonamKhetrapal Singh, Regional Director, WHO SEARO, Dr RK Vats, Additional Secretary, Health Ministry, andDr.HenkBekedam, WHO Representative to India, also graced the occasion.State Health Ministers and Principal Secretaries from several states in India were also present.


Speaking at the function, ShriNadda said that the National Health Policy 2017 is dedicated to the highest possible standards of health for the country. “The Government has launched Ayushman Bharat, a National Health Protection Scheme, which envisions health assurance of 5 lakh rupees (6815 USD) per family per year, will benefit over 50 crore (i.e. 500 million) people, and is the world's biggest health assurance scheme. He further added that since its launch on 23rd September, 2018, more than 50,000 people have availed of services under the scheme.

“These issues require continuous engagement and dialogue.  I believe that the Health Ministry with active partnership of other ministries in Government of India will move forward in leaps and bounds,” he said.  The Union Health Minister further added that India is actively contributing and providing support for the South-East Asia Regulatory Network (SEARN) to guarantee access to high-quality medical products.


Shri Ashwini Kumar Choubey, Minister of State for Health and Family Welfarehighlighted the importance of traditional medical system in achieving the health goals. He stated that strengthening R&D and upholding education standards in the Indian Systems of Medicines, promoting the cultivation of medicinal plants used, and working on Pharmacopoeia standards are areas with positive public health potential outcomes. “The diagnosis of modern medicine combined with the treatment modalities of the Ayurveda, Yoga, Homeopathy and other systems of AYUSH will help in giving a holistic approach to treatment,” ShriChoubey said.

Smt Anupriya Patel, Minister of State for Health and Family Welfare said that Sustainable Development Goals are the mantra for a better future for all and access to medicines is a critical factor for success of the SDG Agenda that aims to ensure healthy lives and promote well-being of all people of all ages. “Universal Health Coverage and access to medicines is also one of the regional flagship priorities for countries in the WHO South-East Asia region,” she added. She stated that India is committed to attainment of the highest possible standards of health for its citizens.

Dr TedrosAdhanomGhebreyesus, Director General, World Health Organization through his video address stated that WHO has embarked on the 13th Global Programme of Work (GPW13) for strategic direction in Sustainable Development Agenda 2030 (SDG) for health which is vital for the future of our world. GPW 13 is structured around the “triple billion” goal for three interconnected strategic priorities of Healthy Lives, Universal Health Coverage and health emergencies. ‘Reliable access to effective, safe, quality-assured and affordable medical products are keys to making progress towards Universal Health Coverage (UHC) and the SDGs,’ he said.

The main objective of the 2nd World Conference 2018 is to take forward the recommendations from the 1st World Conference 2017 and build on the work done for access to medical products in the context of SDGs (including trade agreements) in line with GPW 13 of WHO, foster new approaches in innovation landscape for medical products and health technologies for accelerating research and innovation and identify knowledge, information and policy options on the interface of international trade and health to achieve SDG 2030 goals.

<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Career for Pharmacist / Assistant Pharmacist at HLL Lifecare Limited | walk in

HLL Lifecare Limited, a global provider of high quality healthcare products & services, is a Government of India Enterprise, under the Ministry of Health & Family Welfare, with seven manufacturing units and Marketing offices throughout the country. 

Healthcare Services & Retail Business Divisions of HLL Lifecare Limited has setup HINDLABS Diagnostic Center and Pharmacy Outlets for which the company is looking for candidates in the following positions on Fixed Tenure Contract basis.

Post : Pharmacist / Assistant Pharmacist

Vacancy for Research Associate at Institute of Life Sciences

Institute of Life Sciences (ILS), Bhubaneswar, an autonomous institute of the Department of Biotechnology, Ministry of Science & Technology, Government of India invites applications from Indian Nationals to join in the following position.

Post : Research Associate

Job for Senior Research Associate at Syngene International | Fresher M.Pharm, M.Sc apply

Syngene International is one of India’s premier contract research and manufacturing organizations in providing customized service. Our services encompasses all across discovery chain: early stage discovery, process development, cGMP manufacturing and formulation development both in the small molecule and novel biologics area. Based in Bangalore, Karnataka, the Company is situated in a 90 acre Special Economic Zone with over 100000 sq. mt of built up facilities. The state-of-the-art research facilities have been qualified by various pharmaceutical majors & regulatory agencies and has received various certifications including ISO 9001: 2008, ISO 14001:2004, OHSAS 18001:2007, GLP and AAALAC.

Post : Senior Research Associate - ARD 1